Same occurred to me , Hawkbar ...lining up the ducks in a row ,...

Same occurred to me , Hawkbar ...lining up the ducks in a row , or put another way , getting IMU "match ready " for the big game .
Taken from a Diamond Investment Report of May 2024 , it seems that the Granting of Patents , as distinct from the Activation of the Patents , takes multiple months .
Someone might help me here ..but I think that IMU still has a similar Patent granted and pending for Europe ???
Please confirm ..I would think each Approval adds weight to other approvals being Activated .

Match ready soon ...bloody long pre season , but we hope so !

. • Q3 FY2024 Corporate Update - In Q3 FY2024, Imugene Limited announced a strategic partnership
with Kincell Bio, resulting in the sale of its North Carolina manufacturing facility for up to $6 million
USD. This transaction, expected to save Imugene approximately A$49.0 million (USD $32 million)
in various operational costs, allows the company to focus more on developing novel cancer treatments
while retaining all rights to azer-cel. Additionally, Imugene secured a significant intellectual property
milestone with a new patent in China for its oncolytic virotherapy CF33, further strengthening its
position in major Asian markets until 2037. This patent expansion follows earlier grants in Japan and
South Korea, enhancing Imugene's competitive stance in these critical regions.